181 related articles for article (PubMed ID: 26985398)
1. Spatial separation of the processing and MHC class I loading compartments for cross-presentation of the tumor-associated antigen HER2/
Baleeiro RB; Rietscher R; Diedrich A; Czaplewska JA; Lehr CM; Scherließ R; Hanefeld A; Gottschaldt M; Walden P
Oncoimmunology; 2015 Nov; 4(11):e1047585. PubMed ID: 26985398
[TBL] [Abstract][Full Text] [Related]
2. Generation of populations of antigen-specific cytotoxic T cells using DCs transfected with DNA construct encoding HER2/neu tumor antigen epitopes.
Kuznetsova M; Lopatnikova J; Khantakova J; Maksyutov R; Maksyutov A; Sennikov S
BMC Immunol; 2017 Jun; 18(1):31. PubMed ID: 28633645
[TBL] [Abstract][Full Text] [Related]
3. Cross-presentation: underlying mechanisms and role in immune surveillance.
Rock KL; Shen L
Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylserine receptor-mediated recognition of archaeosome adjuvant promotes endocytosis and MHC class I cross-presentation of the entrapped antigen by phagosome-to-cytosol transport and classical processing.
Gurnani K; Kennedy J; Sad S; Sprott GD; Krishnan L
J Immunol; 2004 Jul; 173(1):566-78. PubMed ID: 15210818
[TBL] [Abstract][Full Text] [Related]
5. Variable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape.
Dinter J; Duong E; Lai NY; Berberich MJ; Kourjian G; Bracho-Sanchez E; Chu D; Su H; Zhang SC; Le Gall S
PLoS Pathog; 2015 Mar; 11(3):e1004725. PubMed ID: 25781895
[TBL] [Abstract][Full Text] [Related]
6. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
[TBL] [Abstract][Full Text] [Related]
7. Intracellular Transport Routes for MHC I and Their Relevance for Antigen Cross-Presentation.
Adiko AC; Babdor J; Gutiérrez-Martínez E; Guermonprez P; Saveanu L
Front Immunol; 2015; 6():335. PubMed ID: 26191062
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation.
Rosalia RA; Quakkelaar ED; Redeker A; Khan S; Camps M; Drijfhout JW; Silva AL; Jiskoot W; van Hall T; van Veelen PA; Janssen G; Franken K; Cruz LJ; Tromp A; Oostendorp J; van der Burg SH; Ossendorp F; Melief CJ
Eur J Immunol; 2013 Oct; 43(10):2554-65. PubMed ID: 23836147
[TBL] [Abstract][Full Text] [Related]
9. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
10. Cross-presentation: how to get there - or how to get the ER.
Kreer C; Rauen J; Zehner M; Burgdorf S
Front Immunol; 2011; 2():87. PubMed ID: 22566876
[TBL] [Abstract][Full Text] [Related]
11. Proteasomal degradation within endocytic organelles mediates antigen cross-presentation.
Sengupta D; Graham M; Liu X; Cresswell P
EMBO J; 2019 Aug; 38(16):e99266. PubMed ID: 31271236
[TBL] [Abstract][Full Text] [Related]
12. ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II.
Schnurr M; Orban M; Robson NC; Shin A; Braley H; Airey D; Cebon J; Maraskovsky E; Endres S
J Immunol; 2009 Feb; 182(3):1253-9. PubMed ID: 19155470
[TBL] [Abstract][Full Text] [Related]
13. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.
Ho NI; Camps MGM; de Haas EFE; Ossendorp F
Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785
[TBL] [Abstract][Full Text] [Related]
14. A Therapeutic Her2/neu Vaccine Targeting Dendritic Cells Preferentially Inhibits the Growth of Low Her2/neu-Expressing Tumor in HLA-A2 Transgenic Mice.
Tran T; Diniz MO; Dransart E; Gey A; Merillon N; Lone YC; Godefroy S; Sibley C; Ferreira LC; Medioni J; Oudard S; Johannes L; Tartour E
Clin Cancer Res; 2016 Aug; 22(16):4133-44. PubMed ID: 27006496
[TBL] [Abstract][Full Text] [Related]
15. Pathways for antigen cross presentation.
Guermonprez P; Amigorena S
Springer Semin Immunopathol; 2005 Jan; 26(3):257-71. PubMed ID: 15592842
[TBL] [Abstract][Full Text] [Related]
16. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells.
Hotta C; Fujimaki H; Yoshinari M; Nakazawa M; Minami M
Immunology; 2006 Jan; 117(1):97-107. PubMed ID: 16423045
[TBL] [Abstract][Full Text] [Related]
17. A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells.
Segura E; Villadangos JA
Traffic; 2011 Dec; 12(12):1677-85. PubMed ID: 21777358
[TBL] [Abstract][Full Text] [Related]
18. Endocytosed soluble cowpox virus protein CPXV012 inhibits antigen cross-presentation in human monocyte-derived dendritic cells.
Spel L; Luteijn RD; Drijfhout JW; Nierkens S; Boes M; Wiertz EJH
Immunol Cell Biol; 2018 Feb; 96(2):137-148. PubMed ID: 29363167
[TBL] [Abstract][Full Text] [Related]
19. Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100.
Lapointe R; Royal RE; Reeves ME; Altomare I; Robbins PF; Hwu P
J Immunol; 2001 Oct; 167(8):4758-64. PubMed ID: 11591807
[TBL] [Abstract][Full Text] [Related]
20. Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens.
Gao J; Ochyl LJ; Yang E; Moon JJ
Int J Nanomedicine; 2017; 12():1251-1264. PubMed ID: 28243087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
